These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 31332290)

  • 1. Iron regulatory protein 2 is a suppressor of mutant p53 in tumorigenesis.
    Zhang Y; Feng X; Zhang J; Chen M; Huang E; Chen X
    Oncogene; 2019 Aug; 38(35):6256-6269. PubMed ID: 31332290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ferredoxin reductase is critical for p53-dependent tumor suppression via iron regulatory protein 2.
    Zhang Y; Qian Y; Zhang J; Yan W; Jung YS; Chen M; Huang E; Lloyd K; Duan Y; Wang J; Liu G; Chen X
    Genes Dev; 2017 Jun; 31(12):1243-1256. PubMed ID: 28747430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDXR regulates TP73 tumor suppressor via IRP2 to modulate aging and tumor suppression.
    Zhang J; Kong X; Zhang Y; Sun W; Wang J; Chen M; Chen X
    J Pathol; 2020 Jul; 251(3):284-296. PubMed ID: 32304229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal cancer progression by mutant p53 through the acquisition of invasiveness associated with complex glandular formation.
    Nakayama M; Sakai E; Echizen K; Yamada Y; Oshima H; Han TS; Ohki R; Fujii S; Ochiai A; Robine S; Voon DC; Tanaka T; Taketo MM; Oshima M
    Oncogene; 2017 Oct; 36(42):5885-5896. PubMed ID: 28628120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ferredoxin reductase gene is regulated by the p53 family and sensitizes cells to oxidative stress-induced apoptosis.
    Liu G; Chen X
    Oncogene; 2002 Oct; 21(47):7195-204. PubMed ID: 12370809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression of ferredoxin reductase predicts outcome in patients with metastatic colorectal cancer treated by 5-fluorouracil plus leucovorin.
    Ichikawa W; Ooyama A; Toda E; Sugimoto Y; Oka T; Takahashi T; Shimizu M; Sasaki Y; Hirayama R
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):794-801. PubMed ID: 16528528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron Regulatory Protein 2 Exerts its Oncogenic Activities by Suppressing TAp63 Expression.
    Zhang Y; Feng X; Zhang J; Chen X
    Mol Cancer Res; 2020 Jul; 18(7):1039-1049. PubMed ID: 32276991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trp53 null and R270H mutant alleles have comparable effects in regulating invasion, metastasis, and gene expression in mouse colon tumorigenesis.
    Tang J; Feng Y; Kuick R; Green M; Green M; Sakamoto N; Kurosu Y; Lin J; Cho KR; Fearon ER
    Lab Invest; 2019 Oct; 99(10):1454-1469. PubMed ID: 31148594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mdm2 is a target and mediator of IRP2 in cell growth control.
    Zhang J; Kong X; Zhang Y; Sun W; Xu E; Chen X
    FASEB J; 2020 Feb; 34(2):2301-2311. PubMed ID: 31907996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutant p53(R270H) gain of function phenotype in a mouse model for oncogene-induced mammary carcinogenesis.
    Heinlein C; Krepulat F; Löhler J; Speidel D; Deppert W; Tolstonog GV
    Int J Cancer; 2008 Apr; 122(8):1701-9. PubMed ID: 18092324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRAF mutations are associated with increased iron regulatory protein-2 expression in colorectal tumorigenesis.
    Horniblow RD; Bedford M; Hollingworth R; Evans S; Sutton E; Lal N; Beggs A; Iqbal TH; Tselepis C
    Cancer Sci; 2017 Jun; 108(6):1135-1143. PubMed ID: 28281325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumorigenic properties of iron regulatory protein 2 (IRP2) mediated by its specific 73-amino acids insert.
    Maffettone C; Chen G; Drozdov I; Ouzounis C; Pantopoulos K
    PLoS One; 2010 Apr; 5(4):e10163. PubMed ID: 20405006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ferredoxin reductase and p53 are necessary for lipid homeostasis and tumor suppression through the ABCA1-SREBP pathway.
    Zhang Y; Mohibi S; Vasilatis DM; Chen M; Zhang J; Chen X
    Oncogene; 2022 Mar; 41(12):1718-1726. PubMed ID: 35121827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide inhibits the degradation of IRP2.
    Wang J; Chen G; Pantopoulos K
    Mol Cell Biol; 2005 Feb; 25(4):1347-53. PubMed ID: 15684386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gain-of-function mutant p53 promotes the oncogenic potential of head and neck squamous cell carcinoma cells by targeting the transcription factors FOXO3a and FOXM1.
    Tanaka N; Zhao M; Tang L; Patel AA; Xi Q; Van HT; Takahashi H; Osman AA; Zhang J; Wang J; Myers JN; Zhou G
    Oncogene; 2018 Mar; 37(10):1279-1292. PubMed ID: 29269868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted Pten deletion plus p53-R270H mutation in mouse mammary epithelium induces aggressive claudin-low and basal-like breast cancer.
    Wang S; Liu JC; Kim D; Datti A; Zacksenhaus E
    Breast Cancer Res; 2016 Jan; 18(1):9. PubMed ID: 26781438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mammary gland-specific ablation of focal adhesion kinase reduces the incidence of p53-mediated mammary tumour formation.
    van Miltenburg MH; van Nimwegen MJ; Tijdens I; Lalai R; Kuiper R; Klarenbeek S; Schouten PC; de Vries A; Jonkers J; van de Water B
    Br J Cancer; 2014 May; 110(11):2747-55. PubMed ID: 24809783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iron regulatory protein 2 deficiency may correlate with insulin resistance.
    Zhou Y; Wu W; Xu Z; Liu Y; Chang H; Yu P; Zhang X; Yang Y; Liu K; Chang Y
    Biochem Biophys Res Commun; 2019 Mar; 510(2):191-197. PubMed ID: 30685084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The gut microbiome switches mutant p53 from tumour-suppressive to oncogenic.
    Kadosh E; Snir-Alkalay I; Venkatachalam A; May S; Lasry A; Elyada E; Zinger A; Shaham M; Vaalani G; Mernberger M; Stiewe T; Pikarsky E; Oren M; Ben-Neriah Y
    Nature; 2020 Oct; 586(7827):133-138. PubMed ID: 32728212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mice expressing a mammary gland-specific R270H mutation in the p53 tumor suppressor gene mimic human breast cancer development.
    Wijnhoven SW; Zwart E; Speksnijder EN; Beems RB; Olive KP; Tuveson DA; Jonkers J; Schaap MM; van den Berg J; Jacks T; van Steeg H; de Vries A
    Cancer Res; 2005 Sep; 65(18):8166-73. PubMed ID: 16166291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.